Detalhe da pesquisa
1.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36632738
2.
Clonal haematopoiesis as a risk factor for therapy-related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo-(immuno)therapy.
Br J Haematol
; 198(1): 103-113, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277855
3.
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Blood
; 135(21): 1859-1869, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267500
4.
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
Hematol Oncol
; 39(3): 326-335, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739461
5.
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations.
Br J Haematol
; 189(5): 853-859, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32064595
6.
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Haematologica
; 105(2): 448-456, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371416
7.
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.
Am J Hematol
; 95(6): 604-611, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32096887
8.
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib.
Br J Haematol
; 184(3): 392-396, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30338509
9.
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia.
Haematologica
; 104(10): 2053-2060, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097627
10.
Pre-exposure prophylaxis with tixagevimab/cilgavimab in patients with chronic lymphocytic leukaemia treated with targeted agents.
Br J Haematol
; 201(3): 564-567, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810731
11.
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics.
Br J Haematol
; 181(2): 229-233, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611195
12.
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report.
Blood
; 136(6): 763-766, 2020 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32559271
13.
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.
Blood
; 126(16): 1921-4, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26276669
14.
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.
Blood
; 123(15): 2378-88, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550227
15.
Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study.
Haematologica
; 106(2): 622-625, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354865
16.
Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.
Eur J Haematol
; 96(1): 36-45, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25753656
17.
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.
Genes Chromosomes Cancer
; 54(4): 222-34, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25645730
18.
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2).
Haematologica
; 105(11): 2671-2674, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131259
19.
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases.
Br J Haematol
; 167(2): 224-32, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25041609
20.
Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR.
Br J Haematol
; 166(3): 360-8, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24735016